Conclusion
MD-CTA is a powerful and continuously evolving technology for noninvasive (minimally invasive) cardiovascular imaging. CM administration is an integral part of this evolution, and needs to be continuously adopted and optimized to take full advantage of this technology. A basic understanding of physiologic and pharmacokinetic principles, as well as an understanding of the effects of injection parameters on arterial enhancement—in terms of injection rate and injection duration—allow the development of optimized CM delivery protocols for current and future vascular MDCT.
Similar content being viewed by others
References
Bae KT, Heiken JP, Brink JA (1998) Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate—pharmacokinetic analysis and experimental porcine model. Radiology 206(2):455–64
Fleischmann D (2002) Present and future trends in multiple detector-row CT applications: CT angiography. Europ Radiol 12:S11-S16
Bae KT, Heiken JP, Brink JA (1998) Aortic and hepatic contrast medium enhancement at CT. Part II. Effect of reduced cardiac output in a porcine model. Radiology 207(3):657–62
Hittmair K, Fleischmann D (2001) Accuracy of predicting and controlling time-dependent aortic enhancement from a test bolus injection. J Comput Assist Tomogr 25(2):287–94
Van Hoe L, Marchal, G, Baert AL, Gryspeerdt S, Mertens L (1995) Determination of scan delay-time in spiral CT-angiography: utility of a test bolus injection. J Comput Assist Tomogr 19(2):216–220
Fleischmann D, Rubin GD, Bankier AA, Hittmair K (2000) Improved uniformity of aortic enhancement with customized contrast medium injection protocols, at CT angiography. Radiology 214(2):363–71
Haage P, Schmitz-Rode T, Hubner D, Piroth W, Gunther RW (2000) Reduction of contrast material dose and artifacts by a saline flush using a double power inject or in helical CT of the thorax. AJR Am J Roentgenol 174(4):1049–53
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fleischmann, D. High-concentration contrast media in MDCT angiography: principles and rationale. Eur Radiol 13 (Suppl 3), N39–N43 (2003). https://doi.org/10.1007/s00330-003-0005-1
Issue Date:
DOI: https://doi.org/10.1007/s00330-003-0005-1